NCT04341012 2026-01-26
Breath Analysis Based Disease Biomarkers
Mayo Clinic
Completed
Clinical Trials
52 trialsNCT04618692 2025-12-18
Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation
Istanbul Medipol University Hospital
Phase NA Completed
NCT06278883 2025-11-20
GRACE
Duke University
Phase NA Completed
NCT06352528 2025-10-06
A Study to Assess the Drug Levels of Repotrectinib in Healthy Participants and Participants With Moderate and Severe Hepatic Impairment
Bristol-Myers Squibb
Phase 1 Completed
NCT02312817 2025-07-15
RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System
University of Texas Southwestern Medical Center
Phase NA Completed
NCT04066153 2025-04-06
Patient Reported Unmet Needs for Function and Supportive Occupational- and Physiotherapy Rehabilitation Interventions
Rigshospitalet, Denmark
Completed
NCT05233098 2025-03-06
TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.
Boston Scientific Corporation
Completed
NCT06425198 2025-01-22
Study to Assess Drug Levels and Safety of BMS-986278 in Healthy Participants and Participants With Different Degrees of Hepatic Impairment
Bristol-Myers Squibb
Phase 1 Completed
NCT06526754 2024-12-18
Feasibility Analysis of LCD-SLA 3D Printing Technology for Overall Surgical Planning of Liver Malignant Tumors
Affiliated Hospital of Hebei University
Phase NA Completed
NCT04926376 2024-11-29
Safety and Effectiveness of Eye90 Microspheresâ„¢ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)
ABK Biomedical
Phase NA Completed
NCT02301104 2024-09-05
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment
Taiho Oncology, Inc.
Phase 1 Completed
NCT03814005 2024-09-05
A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems
Takeda
Phase 1 Completed
NCT02112656 2024-08-20
OPTIMA
Imunon
Phase 3 Completed
NCT00113113 2024-08-02
Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction
Astex Pharmaceuticals, Inc.
Phase 1 Completed
NCT05053412 2024-08-02
HEPATIC
Helio Genomics
Completed
NCT04518852 2024-06-25
TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC
Sichuan Cancer Hospital and Research Institute
Phase 2 Completed
NCT02508467 2024-04-12
A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma
Blueprint Medicines Corporation
Phase 1 Completed
NCT04627012 2024-03-06
Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma
Sun Yat-sen University
Completed
NCT05471596 2024-03-04
MWA
Wake Forest University Health Sciences
Completed
NCT02337673 2023-09-29
Screening of Postoperative Pulmonary Complications by Electrical Impedance Tomography
Johannes Gutenberg University Mainz
Completed
NCT01390194 2023-09-06
Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular Carcinoma
University of Nebraska
Completed
NCT04185454 2023-01-11
Estimation of Minimum Efficacy Daily Dose of Jarlsberg Cheese
Meddoc
Phase NA Completed
NCT04172714 2022-12-06
Low-dose Y90 Treatment Planning for HCC
Emory University
Phase NA Completed
NCT04666558 2022-10-04
PiONEeR
University of Alberta
Phase NA Completed
NCT04375670 2022-08-09
COVID19-FOIE National Observatory
Assistance Publique - Hôpitaux de Paris
Completed
NCT02921828 2022-07-05
A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
Celgene
Completed
NCT01429038 2022-06-14
Mesenchymal Stem Cells After Renal or Liver Transplantation
University of Liege
Phase 1/2 Completed
NCT04639115 2022-06-14
A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild or Moderate Hepatic Impairment on the Multiple-Dose Pharmacokinetics of Ozanimod
Celgene
Phase 1 Completed
NCT02292173 2021-06-10
Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT00543777 2021-04-13
Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT01871545 2020-07-09
Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI)
Icahn School of Medicine at Mount Sinai
Phase NA Completed
NCT00342186 2020-06-16
Genes Involved in Resistance or Susceptibility to Hepatitis B Virus
National Institutes of Health Clinical Center (CC)
Completed
NCT02868242 2020-03-02
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy
Gilead Sciences
Phase 2 Completed
NCT01273155 2019-03-26
Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT01619475 2019-02-08
A2ALL-2
Arbor Research Collaborative for Health
Completed
NCT02073435 2018-12-05
A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation
Northwestern University
Completed
NCT01490203 2018-03-23
LiFE
Seoul National University Hospital
Completed
NCT01177007 2017-08-28
Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors
Yale University
Phase 2 Completed
NCT01825213 2017-04-17
Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT
Massachusetts General Hospital
Completed
NCT01316679 2017-04-12
An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423
Vanderbilt University Medical Center
Completed
NCT00827554 2016-04-01
The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital
Phase 2/3 Completed
NCT00874224 2016-03-09
ORANGE II
Maastricht University Medical Center
Phase NA Completed
NCT01273493 2016-02-15
A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
Janssen Research & Development, LLC
Phase 1 Completed
NCT02329821 2015-07-13
Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic Resection
Samsung Medical Center
Completed
NCT00627042 2014-10-08
Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy
Eli Lilly and Company
Phase 2 Completed
NCT01394497 2013-02-18
Use of N-Acetylcysteine During Liver Procurement
Azienda Ospedaliera di Padova
Phase 2 Completed
NCT00969410 2012-04-12
A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases
AVEO Pharmaceuticals, Inc.
Phase 1 Completed
NCT00526331 2012-01-16
Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy
M.D. Anderson Cancer Center
Phase 4 Completed
NCT00037804 2009-08-14
Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction
Pfizer
Phase 1 Completed
NCT00883454 2009-04-17
Estimation of Functional Liver Reserve Using Cholinesterases
University of Milan
Completed